In this regard, overexpression of anti-apoptotic BCL-2 members (e.g., BCL-2, BCL-XL, MCL-1) is quite frequent in newly diagnosed cancer as well as after developing resistance to therapies [17,18]. The gene discussed is BCL2; the disease is cancer.